COVID-19 and the brain: impact on nuclear medicine in neurology

Morbelli S.
First
;
2020-01-01

2020
47
11
2487
2492
Brain; COVID-19; Clinical Trials as Topic; Delivery of Health Care; Dementia; Health Services Accessibility; Health Services Needs and Demand; Humans; Nervous System Diseases; Neuroimaging; Nuclear Medicine Department; Hospital; Observational Studies as Topic; Olfaction Disorders; Positron-Emission Tomography; Quarantine; SARS-CoV-2; Thrombophilia; Tomography; Emission-Computed; Single-Photon; Betacoronavirus; Coronavirus Infections; Pandemics; Pneumonia; Viral
Morbelli S.; Ekmekcioglu O.; Barthel H.; Albert N. L.; Boellaard R.; Cecchin D.; Guedj E.; Lammertsma A. A.; Law I.; Penuelas I.; Semah F.; Traub-Weidinger T.; van de Giessen E.; Varrone A.; Garibotto V.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1957392
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 15
social impact